BIOVIT — Bio Vitos Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Bio Vitos Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -11.7 | -14 | -14.9 | -12.9 | -18 |
| Depreciation | |||||
| Non-Cash Items | 5.58 | 0.009 | 0 | 0.17 | -0.009 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.11 | -0.662 | -0.131 | -0.636 | 0.226 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.23 | -8.19 | -7.91 | -3.97 | -2.9 |
| Capital Expenditures | -4.59 | -3.36 | -3.99 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | -0.145 | 0.084 |
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -4.59 | -3.36 | -3.99 | -0.145 | 0.084 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.665 | 14 | 6.29 | 4 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -12.5 | 2.42 | -5.6 | -0.114 | -2.81 |